A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆
- DOI
- 10.1016/j.jhepr.2026.102090
- Published
- 2026-11
- Container
- JHEP Reports
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhepr.2026.102090,
title = {A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆},
author = {Alexandra Wolf and Matias Facciuto and Melissa Damiecki and Emily R. Bramel and Eric Park and Sara E. Young and Miguel Torres and Shalini Nath and Vincenzo Mazzaferro and Myron Schwartz and Amaia Lujambio and Benjamin D. Hopkins and Alexander M. Tsankov and Anna Tocheva and Daniela Sia},
year = {2026},
journal = {JHEP Reports},
doi = {10.1016/j.jhepr.2026.102090},
url = {https://doi.org/10.1016/j.jhepr.2026.102090}
}RIS
TY - JOUR TI - A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆ AU - Alexandra Wolf AU - Matias Facciuto AU - Melissa Damiecki AU - Emily R. Bramel AU - Eric Park AU - Sara E. Young AU - Miguel Torres AU - Shalini Nath AU - Vincenzo Mazzaferro AU - Myron Schwartz AU - Amaia Lujambio AU - Benjamin D. Hopkins AU - Alexander M. Tsankov AU - Anna Tocheva AU - Daniela Sia PY - 2026 JO - JHEP Reports DO - 10.1016/j.jhepr.2026.102090 UR - https://doi.org/10.1016/j.jhepr.2026.102090 ER -
APA
Wolf, A., Facciuto, M., Damiecki, M., Bramel, E. R., Park, E., Young, S. E., Torres, M., Nath, S., Mazzaferro, V., Schwartz, M., Lujambio, A., Hopkins, B. D., Tsankov, A. M., Tocheva, A., & Sia, D. (2026). A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆. JHEP Reports. https://doi.org/10.1016/j.jhepr.2026.102090
Source records
- crossref · retrieved 2026-11-04T23:46:21.501Z